[1] FAJGENBAUM D C.Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease[J].Blood,2018,132(22):2323-2330. [2] KELLER A R,HOCHHOLZER L,CASTLEMAN B.Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations[J].Cancer,1972,29(3):670-683. [3] NISHIKORI A,NISHIMURA M F,NISHIMURA Y,et al.Investigation of IgG4-positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4-related disease[J].Pathol Int,2022,72(1):43-52. [4] CHEUK W,CHAN J K.Lymphadenopathy of IgG4-related disease:An underdiagnosed and overdiagnosed entity[J].Semin Diagn Pathol,2012,29(4):226-234. [5] ZOSHIMA T,YAMADA K,HARA S,et al.Multicentric Castleman disease with tubulointerstitial nephritis mimicking IgG4-related disease:Two case reports[J].Am J Surg Pathol,2016,40(4):495-501. [6] UMEHARA H,OKAZAKI K,KAWA S,et al.The 2020 revised comprehensive diagnostic(RCD)criteria for IgG4-RD[J].Mod Rheumatol,2021,31(3):529-533. [7] DESHPANDE V,ZEN Y,CHAN J K,et al.Consensus statement on the pathology of IgG4-related disease[J].Mod Pathol,2012,25(9):1181-1192. [8] HAMANO H,ARAKURA N,MURAKI T,et al.Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis[J].J Gastroenterol,2006,41(12):1197-1205. [9] CHEUK W,YUEN H K,CHU S Y,et al.Lymphadenopathy of IgG4-related sclerosing disease[J].Am J Surg Pathol,2008,32(5):671-681. [10] FAJGENBAUM D C,ULDRICK T S,BAGG A,et al.International,evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease[J].Blood,2017,129(12):1646-1657. [11] JO J H,PARK Y S,JEON Y K,et al.Comparison of plasma cell type of Castleman’s disease and IgG4-related sclerosing disease:A histopathological and immunohistochemical study[J].Pathobiology,2011,78(4):227-232. [12] SATO Y,KOJIMA M,TAKATA K,et al.Systemic IgG4-related lymphadenopathy:A clinical and pathologic comparison to multicentric Castleman’s disease[J].Mod Pathol,2009,22(4):589-599. [13] SATO Y,KOJIMA M,TAKATA K,et al.Multicentric castleman’s disease with abundant IgG4-positive cells:A clinical and pathological analysis of six cases[J].J Clin Pathol,2010,63(12):1084-1089. [14] SATOU A,NOTOHARA K,ZEN Y,et al.Clinicopathological differential diagnosis of IgG4-related disease:A historical overview and a proposal of the criteria for excluding mimickers of IgG4-related disease[J].Pathol Int,2020,70(7):391-402. [15] ZHANG X,ZHANG P,PENG L,et al.Clinical characteristics of a concurrent condition of IgG4-RD and castleman’s disease[J].Clin Rheumatol,2018,37(12):3387-3395. |